Dynaverse.net

Off Topic => Engineering => Topic started by: Nemesis on April 19, 2009, 11:29:41 am

Title: Age-related macular degeneration
Post by: Nemesis on April 19, 2009, 11:29:41 am

Link to full article (http://www.timesonline.co.uk/tol/news/uk/health/article6122757.ece)

Quote

The treatment involves replacing a layer of degenerated cells with new ones created from embryonic stem cells. It was pioneered by scientists and surgeons from the Institute of Ophthalmology at University College London and Moorfields eye hospital.

This week Pfizer, the world’s largest pharmaceutical research company, will announce its financial backing to bring the therapy to patients.

Title: Re: Age-related macular degeneration
Post by: Sarek on April 19, 2009, 12:56:16 pm

I have to admit that embryonic stem cell research appears to be a boon for veterinary medicine.  I haven't seen much progress treating human diseases though.

Title: Re: Age-related macular degeneration
Post by: marstone on April 19, 2009, 01:20:18 pm

Quote from: Sarek on April 19, 2009, 12:56:16 pm

I have to admit that embryonic stem cell research appears to be a boon for veterinary medicine.  I haven't seen much progress treating human diseases though.

Question I have is how much anti-rejection drugs are needed for embryonic stem cell treatment.  Is it a lifetime thing, as when you get a new organ.  I would figure that the use of the alternative Stem Cells (although alittle harder to get, but come from the person being treated) would be a better choice, just not as easy.  You would have any rejection problems.